Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Tucci

Showing results (71-80 of 154) with videos related to

Pageof 16
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|November 3, 2021
'Le Roi est mort, vive le Roi': New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With ImmunotherapyAndrea Emanuele Guerini, Andrea Riccardo Filippi, Alessandra Tucci, et al.
Haematologica|April 3, 2025
Early identification of functional high-risk multiple myeloma patients after transplant: the predictive power of fat fraction and Response Assessment Category score in diffusion-weighted whole-body magnetic resonance imagingAngelo Belotti, Barbara Frittoli, Sofia Terlizzi, et al.
Technology in Cancer Research & Treatment|June 18, 2025
The Role of Radiotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Post-CAR-T Therapy: A Systematic Literature ReviewAndrea Emanuele Guerini, Eneida Mataj, Paolo Borghetti, et al.
Leukemia & Lymphoma|March 23, 2013
Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana LinfomiFrancesco Merli, Stefano Luminari, Giuseppe Rossi, et al.
Journal of Cancer Research and Clinical Oncology|November 17, 2020
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experienceAlessandro Alghisi, Paolo Borghetti, Marta Maddalo, et al.
Haematologica|December 22, 2022
IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphomaMaria Cristina Pirosa, Marianna Sassone, Barbara Kiesewetter, et al.
Hematological Oncology|September 19, 2020
Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemiaErika Borlenghi, Chiara Cattaneo, Elisa Cerqui, et al.
Cancer Research|May 12, 2018
slan<sup>+</sup> Monocytes and Macrophages Mediate CD20-Dependent B-cell Lymphoma Elimination via ADCC and ADCPWilliam Vermi, Alessandra Micheletti, Giulia Finotti, et al.
Leukemia & Lymphoma|August 12, 2014
Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)Alessandra Tucci, Maurizio Martelli, Luigi Rigacci, et al.
Blood|November 16, 2020
Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88Antonio Sacco, Cinzia Federico, Arianna Giacomini, et al.
Pageof 16

Showing results (71-80 of 154) with videos related to

Sort By:
Pageof 16
Clinical Lymphoma, Myeloma & Leukemia|November 3, 2021
'Le Roi est mort, vive le Roi': New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With ImmunotherapyAndrea Emanuele Guerini, Andrea Riccardo Filippi, Alessandra Tucci, et al.
Haematologica|April 3, 2025
Early identification of functional high-risk multiple myeloma patients after transplant: the predictive power of fat fraction and Response Assessment Category score in diffusion-weighted whole-body magnetic resonance imagingAngelo Belotti, Barbara Frittoli, Sofia Terlizzi, et al.
Technology in Cancer Research & Treatment|June 18, 2025
The Role of Radiotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Post-CAR-T Therapy: A Systematic Literature ReviewAndrea Emanuele Guerini, Eneida Mataj, Paolo Borghetti, et al.
Leukemia & Lymphoma|March 23, 2013
Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana LinfomiFrancesco Merli, Stefano Luminari, Giuseppe Rossi, et al.
Journal of Cancer Research and Clinical Oncology|November 17, 2020
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experienceAlessandro Alghisi, Paolo Borghetti, Marta Maddalo, et al.
Haematologica|December 22, 2022
IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphomaMaria Cristina Pirosa, Marianna Sassone, Barbara Kiesewetter, et al.
Hematological Oncology|September 19, 2020
Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemiaErika Borlenghi, Chiara Cattaneo, Elisa Cerqui, et al.
Cancer Research|May 12, 2018
slan<sup>+</sup> Monocytes and Macrophages Mediate CD20-Dependent B-cell Lymphoma Elimination via ADCC and ADCPWilliam Vermi, Alessandra Micheletti, Giulia Finotti, et al.
Leukemia & Lymphoma|August 12, 2014
Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)Alessandra Tucci, Maurizio Martelli, Luigi Rigacci, et al.
Blood|November 16, 2020
Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88Antonio Sacco, Cinzia Federico, Arianna Giacomini, et al.
Pageof 16